SEC Form 4 · accession 0001062993-18-003109
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Wegman
Officer — President · Director
Period of report
Aug 2, 2018
Accepted (ET)
Aug 2, 2018 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Aug 2, 2018 | C | 50,000 | $21.00 | A | 336,327 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $21.00 | Aug 2, 2018 | C | 50,000 | D | Aug 2, 2018 | Aug 2, 2018 | Common Stock, $.001 par value | 50,000 | 0 | D |